Question: PARP inhibitor resistance mechanisms and reversal strategies

HDAC inhibitor combination to resensitize PARPi-resistant BRCA-mutant cells

Collecting findings

0/3 publication-ready

Findings metrics

—

total

—

verified

—

pending

—

rejected